Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;37(3):276-278.
doi: 10.37201/req/149.2023. Epub 2024 Mar 27.

Dalbavancin as long-term treatment in Corynebacterium striatum Infections: a literature review

M Camara-Rodriguez, F Jover-Diaz  1 , E Delgado-Sánchez, A Infante-Urríos, J Peris-García
Affiliations
Review

Dalbavancin as long-term treatment in Corynebacterium striatum Infections: a literature review

M Camara-Rodriguez et al. Rev Esp Quimioter. 2024 Jun.
No abstract available

Keywords: Corynebacterium; Dalbavancin; literature review; outpatient parenteral antimicrobial therapy.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest

References

    1. Fernández-Esgueva M, et al. . Infección de prótesis de rodilla por Corynebacterium striatum. Enferm Infecc Microbiol Clin.2019;37:480–491. doi: 10.1016/j.eimc.2018.05.007. - DOI - PubMed
    1. Streifel AC, Varley CD, Ham Y, Sikka MK, Lewis JS 2nd. The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report. BMC Infect Dis. 2022;22:290. doi: 10.1186/s12879-022-07270-0. - DOI - PMC - PubMed
    1. Hernandez NM, Buchanan MW, Cullen MM, Crook BS, Bolognesi MP, Seidelman J, et al. . Corynebacterium total hip and knee arthroplasty prosthetic joint infections. Arthroplasty Today. 2020;6:163–8. doi: 10.1016/j.artd.2020.03.008 - DOI - PMC - PubMed
    1. Chauvelot P, Ferry T, Tafani V, Diot A, Tasse J, Conrad A, et al. . Bone and joint infection involving Corynebacterium spp.: From clinical features to pathophysiological pathways. Frontiers in Medicine. 2021;7. doi: 10.3389/fmed.2020.539501. - DOI - PMC - PubMed
    1. Rolston KV, Wang W, Nesher L, Shelburne SA, Prince RA. In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. J Antibiot (Tokyo). 2016; 69:381-7. doi: 10.1038/ja.2015.120. - DOI - PubMed

MeSH terms

Supplementary concepts